In this next installment of the NIH’s All About Grants podcast series, we will get into the nuts and bolts of what NIH grantees should know about intellectual property, invention reporting, and patent protections. Scott Cooper, J.D., an Assistant Extramural Inventions Policy Officer with the NIH Office of Extramural Research, joins us virtually to discuss these topics (including invention disclosures) in more detail.
George Kennedy, NIAID Brian O’Laughlin, NIDA Yes, we are talking about contracts in this next installment of the NIH’s All About Grants podcast series. Our guests will be George Kennedy and Brian O’Laughlin, who are acquisition staff from the National Institute of Allergy and Infectious Diseases and National Institute on Drug Abuse, respectively. The conversation … Continue reading “New “All About Grants” Podcast – All About Contracts”
In our next installment of the NIH’s All About Grants podcast series we sit down with the Director of the National Institute of General Medical Sciences, Dr. Jon Lorsch, to chat about diversity.
When dutifully scanning the weekly Table of Contents email for the NIH Guide for Grants and Contracts every Friday afternoon, have you found yourself wondering where all the Notices of Special Interest (NOSI) came from? And, what is a NOSI anyways? Dr. Jodi Black, Deputy Director of NIH’s Office of Extramural Research, joins us in … Continue reading “New “All About Grants” Podcast on Notices of Special Interest (NOSIs)”
In this next installment of the NIH’s All About Grants podcast series, we delve into what you should know about certificates. Lyndi Lahl, a Human Subjects Officer within the NIH’s Office of Extramural Research, explains exactly what are certificates, when is disclosure of participant data allowed and when it is not, how to know if your study should have a certificate to protect participants, where to find a certificate associated with your study, and much more.
This series aims to raise awareness and inspire creative problem solving of the challenges in maintaining integrity in peer review. In this case, Dr. Smith, who is being considered as a reviewer for the application, is a professional associate of Dr. Jones, the PI on the application. However, Dr. Smith had not declared a conflict with that application.
Sexual harassment is a serious and long-standing issue within the biomedical research enterprise, and NIH is striving to be part of the solution. On this episode of the “All About Grants” podcast, we sit down with Dr. Jodi Black, Deputy Director for the NIH’s Office of Extramural Research, to discuss what institutions, investigators, and others in the research community should know about NIH’s policies and expectations for assuring a safe and harassment-free work environment.
In this next installment of the “All About Grants” podcast series, small business innovators can learn more about programs geared towards women-owned companies or those led by socially or economically disadvantaged groups.
For decades, NIH has required valid analysis, also known as stratified analysis, to explore how well interventions work across sex/gender and race/ethnicity for all applicable clinical trials. After revising the policy last year, NIH now requires the findings from these stratified analyses to be reported on ClinicalTrials.gov after an applicable NIH-Defined Phase III clinical trial has completed. Wondering about how this impacts your research?
Starting January 29, 2019, NIH will begin implementing the Inclusion Across the Lifespan policy, which requires the consideration of age, along with sex/gender and race/ethnicity, in applications that involve human participants. What does this policy mean for you and your study?